Search for: "Anda Inc." Results 101 - 120 of 962
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Galderma Laboratories, L.P. v. Amneal Pharmaceuticals LLC (Fed. Cir. 2020)
29 Mar 2020, 9:55 pm by Patent Docs
Hospira, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
DOE Infringers Petition for Certiorari over PHE "Tangential Relationship" Test
18 Mar 2020, 9:55 pm by Patent Docs
In three cases (stemming in one instance from a Federal Circuit opinion consolidated from two cases in the district court, by Eli Lilly & Co. against two ANDA defendants),... [read post]
Patent Docs - http://www.patentdocs.org/
HB 20-1046 - Private Retainage Reform - Postponed Indefinetely
19 Feb 2020, 8:35 am by David M. McLain
 Scott Deering, ASAC Legislative Chair and CCC Vice Chair | Absolute Caulking & Waterproofing, Inc., commented “Though we hoped to celebrate the passage of HB20-1046 this year, we know that rarely is a bill passed the first year it is introduced. [read post]
Colorado Construction Litigation - http://www.coloradoconstructionlitigation.com/
State of California and Others to Manufacture Generic Drugs
17 Feb 2020, 1:33 pm by Unknown
The subsidiary will acquire and develop Abbreviated New Drug Applications (ANDAs) for select generic drugs and partner with Civica and manufacturing partners to bring more affordable generic drugs to uncompetitive markets in exchange for aggregated volume and multiyear purchasing commitments. [read post]
IP Finance - http://www.ip.finance/?m=1
The Attack on Colorado’s Construction Industry Continues at the State Legislature
17 Feb 2020, 10:07 am by Unknown
Metro Homes, Inc., 2017 CO 69, 395 P.3d 788. [read post]
Colorado Construction Litigation - http://www.coloradoconstructionlitigation.com/
Hospira, Inc. v. Fresenius Kabi USA, LLC (Fed. Cir. 2020)
14 Jan 2020, 9:10 pm by Patent Docs
The issue arose in ANDA litigation, where the District Court found claim 6 of U.S. [read post]
Patent Docs - http://www.patentdocs.org/
CAFC Affirms District Court Finding that Hospira Precedex Patent Claim is Obvious
10 Jan 2020, 9:15 am by Nancy Braman
The ‘106 patent, owned by Hospira, Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Hospira loses appeal at CAFC. Concept of "harmless error".
9 Jan 2020, 4:50 pm by Lawrence B. Ebert
Hospira, Inc. v. [read post]
IPBiz - http://ipbiz.blogspot.com/
Amgen Inc. v. Amneal Pharmaceuticals LLC (Fed. Cir. 2020)
8 Jan 2020, 8:57 pm by Patent Docs
The case arose in ANDA... [read post]
Patent Docs - http://www.patentdocs.org/
Opening a Closed Markush Group
8 Jan 2020, 11:16 am by Dennis Crouch
” Intervet Inc. v. [read post]
Patently-O - http://patentlyo.com/patent
HZNP Medicines LLC v. Actavis Laboratories UT, Inc. (Fed. Cir. 2019)
16 Oct 2019, 9:59 pm by Patent Docs
Actavis Laboratories UT, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Federal Circuit Decision Delays Generic Osteoarthritis Drug
14 Oct 2019, 2:15 pm by Nancy Braman
Actavis Laboratories UT, Inc. affirming the U.S. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Statements of Efficacy and Safety Material Claim Limitations
3 Sep 2019, 7:41 am by Antoinette F. Konski
Sandoz, Inc., (Fed. [read post]
Personalized Medicine Bulletin - https://www.foley.com/en/insights/blogs/personalized-medicine-bulletin
Federal Circuit Finds Method Withholding Treatment Ineligible For Patenting
3 Sep 2019, 2:03 am by Courtenay C. Brinckerhoff
The INOMax® Patents At Issue  The underlying ANDA litigation involved a number of Orange Book-listed patents for INOMax®, including U.S. [read post]
PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents
‘Substantially Equivalent’ Disclosure May Satisfy Written Description Requirement Under Certain Circumstances
30 Aug 2019, 4:15 am by Dustin Weeks
The Federal Circuit recently affirmed in part and reversed in part a district court decision holding that Actavis Laboratories FL, Inc. [read post]
IPWatchdog - http://www.ipwatchdog.com/
‘Substantially Equivalent’ Disclosure May Satisfy Written Description Requirement Under Certain Circumstances
30 Aug 2019, 4:15 am by Dustin Weeks
The Federal Circuit recently affirmed in part and reversed in part a district court decision holding that Actavis Laboratories FL, Inc. [read post]
IPWatchdog.com | Patent Copyright Trademark - http://www.ipwatchdog.com
Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLC (Fed. Cir. 2019)
27 Aug 2019, 9:59 pm by Patent Docs
The case arose in ANDA litigation involving Sanofi's Jevtana® (cabazitaxel), having the structure: where the methoxy... [read post]
Patent Docs - http://www.patentdocs.org/
Federal Circuit Contrives Substantially Similar Written Description Test
27 Aug 2019, 2:03 am by Courtenay C. Brinckerhoff
In contrast to its decision in Nuvo Pharmaceuticals, Inc. v. [read post]
PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents
Nalproprion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc. (Fed. Cir. 2019)
20 Aug 2019, 9:59 pm by Patent Docs
Actavis Laboratories FL, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Doctrine Of Equivalents Not Barred By Claim Amendments
20 Aug 2019, 2:05 am by Courtenay C. Brinckerhoff
The accused ANDA products contained pemetrexed ditromethamine, not pemetrexed disodium. [read post]
PharmaPatents - https://www.foley.com/en/insights/blogs/pharmapatents